Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Intervalo de año de publicación
1.
Eur J Obstet Gynecol Reprod Biol ; 264: 368-373, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-34399105

RESUMEN

OBJECTIVE: To compare and evaluate the results and suitability of two different approaches to the treatment of post-conization International Federation of Gynaecology and Obstetrics (FIGO) stage IA1 cervical carcinoma: a more radical approach, directly scheduling a second surgery versus a more conservative one, which consists of performing a cotest (PAP plus HPV-test) in a follow-up visit and deciding whether to apply a second surgery on the basis of the results. STUDY DESIGN: Retrospective descriptive study including 144 cases of stage IA1 cervical carcinoma diagnosed after a loop electrosurgical excisional procedure (conization), between 1987 and 2019 in the Mother-and-Child University Hospital of Gran Canaria (Spain). Selected patients were split into two groups for analysis: patients directly undergoing a second surgical intervention (hysterectomy or re-conization) after diagnosis and patients who were followed-up before making a decision whether to schedule a second surgery or continue to follow-up. RESULTS: 75% of women directly receiving a second surgical intervention (no post-conization follow-up) underwent hysterectomy, while 25% underwent re-conization. Histological outcomes from hysterectomized patients showed 65% negative results for intraepithelial lesions, 9% low-grade squamous intraepithelial lesions (LSIL), 16% high-grade squamous intraepithelial lesions (HSIL) and only 10.5% confirmed invasive lesions: hysterectomy complication rate was 7%. Histological studies from women subjected to re-conization showed 32% negative results, 37% LSIL, 5% HSIL and 26% malignancy. In the group of patients who were followed-up after diagnosis, 8.8% needed a second intervention; none of them showed negative histological results, while 100% hysterectomized and 25% patients with re-conization showed HSIL. No unnecessary hysterectomy procedures were conducted in this group. HPV-16 was the most common genotype in both groups. CONCLUSION: Conization proved to be a suitable alternative to hysterectomy as a treatment for post-conization stage IA1 cervical cancer. Our results showed that 65% hysterectomy procedures conducted without previously monitoring for residual disease corresponded to negative results and were therefore, unnecessary. We conclude that confirmation of the presence of residual disease by using cotest is essential to make a decision on further treatment and that a conservative management is often possible and, in our opinion, preferable.


Asunto(s)
Carcinoma de Células Escamosas , Neoplasias del Cuello Uterino , Carcinoma de Células Escamosas/cirugía , Conización , Células Epiteliales , Femenino , Humanos , Histerectomía , Embarazo , Estudios Retrospectivos , Neoplasias del Cuello Uterino/cirugía
2.
Acta Obstet Gynecol Scand ; 96(10): 1205-1213, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28574580

RESUMEN

INTRODUCTION: The purpose of this study was to describe the echographic features and perinatal outcomes of fetuses with absence of ductus venosus. MATERIAL AND METHODS: Retrospective review of 10 cases with absence of ductus venosus diagnosed by prenatal ultrasonography between January 2014 and February 2016 at a single referral center. Prenatal findings, umbilical shunting type, perinatal outcomes, and autopsy reports were reviewed. RESULTS: A total of 11 491 fetuses underwent a first- and second-trimester screening during the study period. Ten cases of absence of ductus venosus were diagnosed. All of the fetuses presented an extrahepatic shunt: three fetuses from the umbilical vein to the right atrium and the seven remaining fetuses from the umbilical vein to the inferior vena cava. Major structural defects and fetal effusions were detected in six fetuses. There were two cases of chromosomal abnormalities. Five patients underwent legal termination of pregnancy and five decided to carry to term. In two of these, the absence of ductus venosus anomaly was isolated and had a normal outcome. In the remaining three cases, a follow up of the children showed a variety of adverse outcomes. CONCLUSIONS: The absence of ductus venosus is associated with high rates of adverse perinatal outcomes. The prognosis for this group of anomalies depends on the additional findings with targeted ultrasound. This pathology should lead to a detailed anatomical study and affected fetuses should be closely monitored for signs of congestive heart failure.


Asunto(s)
Anomalías Congénitas/epidemiología , Enfermedades Fetales/diagnóstico por imagen , Feto/irrigación sanguínea , Venas Umbilicales/anomalías , Humanos , Estudios Retrospectivos , Ultrasonografía Prenatal , Venas Umbilicales/diagnóstico por imagen
3.
Prog. obstet. ginecol. (Ed. impr.) ; 60(3): 226-231, mayo-jun. 2017. tab
Artículo en Español | IBECS | ID: ibc-164066

RESUMEN

El objetivo es analizar los resultados perinatales y obstétricos de las gestaciones en cuya ecografía del primer trimestre se objetivó translucencia nucal incrementada. Obtuvimos 170 translucencias nucales aumentadas (mayor o igual a 3,5 mm), en 62 casos (36,47%) el cariotipo fue normal, en 84 casos (49,41%) fue patológico y en 24 casos (14,11%) no se realizó técnica invasiva. Del total de cariotipos normales (62 casos), 47 gestaciones llegaron a término con parto en nuestro centro y recién nacido normal, dos abortos tras realización de técnica invasiva y hubo diez interrupciones legales del embarazo. Los hallazgos ecográficos encontrados son los siguientes: un caso con megavejiga (2,12%), un caso con onfalocele (2,12%), dos casos de higroma quístico (4,3%), dos hidrops fetales severos, ambos con canal aurícoventricular completo, dos ausencias del hueso nasal (4,3%) y cuatro comunicaciones interventriculares (8,5%). En cuanto al total de translucencia nucal incrementada, 39 casos se correspondieron con trisomía del par 21 (23%), 18 con de trisomía 18 (10,6%), 10 con trisomía 13 (5,9%), 14 con 45XO (8,2%), 1 con 47XXX, (0,7% ), 1 con trisomía 10 (0,7%) y 1 con translocación balanceada 45 XX (t 8;21) (p11;q11)(0,7%). El incremento del grosor de la translucencia nucal entre las 11 y 13 semanas y seis días constituye una expresión fenotípica común de las aneuploidías y una gama de malformaciones fetales y síndromes genéticos. En los fetoseuploides, la prevalencia de las anormalidades fetales y los resultados perinatales adversos aumenta con el incremento de la translucencia nucal (AU)


The objective was to analyze the perinatal and obstetric outcomes of pregnancies, in which increased NT was detected onfirst-trimesterroutine ultrasoundstudy. A total of 170 cases of increased nuchal translucency (equal to or higher than 3.5mm)were detected. Within these cases, 62 (36,47%) had normal karyotype, 84 (49,41%) had aneuplody and 24 (14,11%) were not subjected to invasive techniques. From the group of patients with augmented nuchal translucency and normal karyotype (62), 47 reached full-term delivery at our hospital and the newborns were normal; 2 ended in miscarriage after undergoing an invasive technique, 10 ended in legal termination of pregnancy and 3 did not give birth at our hospital and their data were not available. Ultrasound findings in these patients included: one case of megacystis (2,12%), one case of omphalocele (2,12%), two cases of cystic hygroma (4,3%), two cases of severe hydrops fetalis both with complete AV canal (4,3%), two cases of absent nasal bone (4,3%) and four cases of interventricular communication (IVC) (8,5%). From the total of cases of increased nuchal translucency, 39 corresponded to trisomy-21 (23%); 18 (10,6%) to trisomy-18; 10 to trisomy-13 (5,9%); 14 to Turner’s syndrome (8,2%), 1 to karyotype 47XXX (0,7%); 1 to trisomy-10 (0,7%) and 1 to balanced translocation 45 XX (t 8;21) (p11;q11) (0,7%). Nuchal translucency thickening between weeks 11 and 13+6 days is a common phenotypical manifestation of a neuploidy and a wide range of fetal malformations and genetic syndromes. In euploid fetuses, the prevalence of fetal abnormal findings and adverse perinatal outcome increases with the nuchal translucency value (AU)


Asunto(s)
Humanos , Medida de Translucencia Nucal/instrumentación , Medida de Translucencia Nucal/métodos , Medida de Translucencia Nucal/efectos de la radiación , Ultrasonografía Prenatal/métodos , Diagnóstico Prenatal , Medida de Translucencia Nucal/tendencias , Primer Trimestre del Embarazo/efectos de la radiación , Estudios Retrospectivos , Desarrollo Fetal/efectos de la radiación , Encuestas y Cuestionarios
5.
Prog. obstet. ginecol. (Ed. impr.) ; 59(3): 160-165, mayo-jun. 2016. tab, ilus
Artículo en Español | IBECS | ID: ibc-163857

RESUMEN

Presentamos un caso de un síndrome del espejo causado por infección por parvovirus B19 que se resolvió espontáneamente. El síndrome del espejo es una patología muy poco frecuente, asociada a diferentes causas de hidrops fetal. Se caracteriza por hidrops fetal, edemas maternos y placentomegalia en diferentes grados de manifestación. Realizamos la revisión de 11 casos descritos previamente en la literatura (AU)


We report a case of mirror syndrome caused by parvovirus B19, which resolved spontaneously. Mirror syndrome is a rare condition, associated with different causes of foetal hydrops. The syndrome is characterised by a triad of foetal hydrops, generalized maternal oedema, and placentomegaly of differing severity. We review 11 cases previously reported in the literature (AU)


Asunto(s)
Humanos , Femenino , Embarazo , Adulto , Parvovirus B19 Humano/aislamiento & purificación , Infecciones por Parvoviridae/complicaciones , Infecciones por Parvoviridae/transmisión , Hidropesía Fetal/fisiopatología , Amniocentesis , Cardiomegalia/complicaciones , Cardiomegalia/diagnóstico , Edema/complicaciones , Extremidad Inferior/fisiopatología , Oliguria/complicaciones , Cordocentesis , Ascitis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...